Gene Variants and Haplotypes Modifying Transcription Factor Binding Sites in the Human Cyclooxygenase 1 and 2 (PTGS1 and PTGS2) Genes

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|15|2|182-195

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.15, Iss.2, 2014-02, pp. : 182-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pyrosequencing™™ of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance

By Skarke Carsten   Schuss Patrick   Kirchhof Anja   Doehring Alexandra   Geißßlinger Gerd   Löötsch Jöörn  

Pharmacogenomics, Vol. 8, Iss. 12, 2007-12 ,pp. : 1643-1660

Future Medicine

Access to resources Recommend Favorite

Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation

By Gilroy D.W.   Tomlinson A.   Willoughby D.A.  

European Journal of Pharmacology, Vol. 355, Iss. 2, 1998-08 ,pp. : 211-217

Elsevier

Access to resources Recommend Favorite

The Role of the Transcription Factor E2F1 in Hepatocellular Carcinoma

By  

Current Drug Delivery, Vol. 14, Iss. 2, 2017-02 ,pp. : 272-281

Bentham Science Publishers

Access to resources Recommend Favorite

Induced secretion of insulin-like growth factor binding protein-1 (IGFBP-1) in human hepatoma cell HepG2 by rubratoxin B

By Nagashima Hitoshi   Maeda-Nakamura Kumiko   Iwashita Keiko   Goto Tetsuhisa  

Archives of Toxicology, Vol. 81, Iss. 5, 2007-05 ,pp. : 347-351

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of binding parameters of 1 and 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes

By Nguyen V.H.   Kassiou M.   Johnston G.A.R.   Christie M.J.  

European Journal of Pharmacology, Vol. 311, Iss. 2, 1996-09 ,pp. : 233-240

Elsevier

Access to resources Recommend Favorite